Inventor · disambiguated record
Marie Kosco-Vilbois
Also filed as: KOSCO-VILBOIS MARIE
30 granted patents·13 pending applications·359 citations·filing 2001–2024
96Inventor score
Top patents by PatentIndex Score
43 records- 0198US7728114B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2005·Granted Jun 1, 2010·260 cites·25 claims
- 0293US8034344B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2009·Granted Oct 11, 2011·19 cites·6 claims
- 0391US7786268B2Anti-IP-10 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2008·Granted Aug 31, 2010·14 cites·11 claims
- 0490US10759862B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·3 cites·6 claims
- 0588US8551478B2Anti-CD3 antibodies and methods of use thereofMACH BERNARD·Filed 2010·Granted Oct 8, 2013·14 cites·14 claims
- 0685US9850304B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Dec 26, 2017·5 cites·3 claims
- 0784US9828430B2Anti-IL-6/IL-6R antibodiesNOVIMMUNE SA·Filed 2016·Granted Nov 28, 2017·3 cites·4 claims
- 0884US8258267B2Human anti-IP-10 antibodies uses thereofFISCHER NICOLAS·Filed 2008·Granted Sep 4, 2012·5 cites·7 claims
- 0983US9234034B2Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodiesNOVIMMUNE SA·Filed 2012·Granted Jan 12, 2016·4 cites·5 claims
- 1081US10759858B2Anti-CD3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2017·Granted Sep 1, 2020·1 cites·14 claims
- 1179US8921281B2Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variantsFISCHER NICOLAS·Filed 2010·Granted Dec 30, 2014·4 cites·38 claims
- 1279US8337849B2Anti-IL6/IL-6R antibodiesFERLIN WALTER·Filed 2011·Granted Dec 25, 2012·4 cites·5 claims
- 1378US2024400720A1Anti-cd47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2024·Application pending·0 cites
- 1474US11613582B2Anti-IL-6/IL-6R antibodies and methods of use thereofNOVIMMUNE SA·Filed 2020·Granted Mar 28, 2023·0 cites·2 claims
- 1574US10421809B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2016·Granted Sep 24, 2019·2 cites·8 claims
- 1674US10400044B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 1774US9512221B2Anti-TLR4 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2014·Granted Dec 6, 2016·3 cites·6 claims
- 1874US8716196B2Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variantsFISCHER NICOLAS·Filed 2010·Granted May 6, 2014·2 cites·35 claims
- 1974US2022324994A1Anti-tlr4 antibodies and uses thereofNOVIMMUNE SA·Filed 2021·Application pending·0 cites
- 2073US11059910B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jul 13, 2021·1 cites·7 claims
- 2173US8012474B2Anti-RANTES antibodiesNOV IMMUNE S A·Filed 2008·Granted Sep 6, 2011·3 cites·13 claims
- 2272US9453076B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2013·Granted Sep 27, 2016·1 cites·13 claims
- 2371US2021009691A1Anti-cd3 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2020·Application pending·0 cites
- 2470US10982004B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2019·Granted Apr 20, 2021·0 cites·11 claims
- 2569US7541435B2Antagonists of cxcr3-binding cxc chemokinesMERCK SERONO SA·Filed 2003·Granted Jun 2, 2009·4 cites·23 claims
- 2668US8734790B2Anti-TLR4 antibodies and methods of use thereofKOSCO-VILBOIS MARIE·Filed 2012·Granted May 27, 2014·3 cites·13 claims
- 2763US11840553B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2018·Granted Dec 12, 2023·0 cites·2 claims
- 2862US7402303B2Chemokine mutants in the treatment of multiple sclerosisSERONO LAB·Filed 2001·Granted Jul 22, 2008·1 cites·2 claims
- 2962US7335350B2Chemokines mutants having improved oral bioavailabilitySERONO LAB·Filed 2003·Granted Feb 26, 2008·1 cites·3 claims
- 3062US2020239566A1Anti-tlr4 antibodies and uses thereofNOVIMMUNE SA·Filed 2019·Application pending·0 cites
- 3160US7553483B2Chemokine mutants acting as chemokine antagonistsMERCK SERONO SA·Filed 2002·Granted Jun 30, 2009·1 cites·20 claims
- 3257US2013216549A1Anti-IP-10 Antibodies and Uses ThereofFISCHER NICOLAS·Filed 2012·Application pending·0 cites
- 3357US2015119294A1Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variantsNOVIMMUNE SA·Filed 2014·Application pending·0 cites
- 3456US8110661B2Anti-IP-10 antibodies and methods of use thereofFISCHER NICOLAS·Filed 2010·Granted Feb 7, 2012·0 cites·7 claims
- 3554US2015079099A1Anti-RANTES AntibodiesNOVLMMUNE S A·Filed 2014·Application pending·0 cites
- 3654US2015005201A1Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variantsNOVIMMUNE SA·Filed 2014·Application pending·0 cites
- 3753US8673299B2Anti-RANTES antibodiesFISCHER NICOLAS·Filed 2011·Granted Mar 18, 2014·0 cites·13 claims
- 3852US2007065437A1Anti-CD3 antibody formulationsELSON GREG·Filed 2006·Application pending·0 cites
- 3952US2010209437A1Anti-CD3 Antibody FromulationsELSON GREG·Filed 2006·Application pending·0 cites
- 4044US2025340623A1Novel Molecules for Therapy and DiagnosisAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 4141US2004247598A1Use of il-18 inhibitors in hypersensitivity disordersFiled 2002·Application pending·0 cites
- 4238US7425324B2Antagonists of MCP proteinsSERONO LAB·Filed 2003·Granted Sep 16, 2008·0 cites·28 claims
- 4337US2005265993A1Methods of treating autoimmune and inflammatory diseasesMACH BERNARD·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →